Marshall Wace, LLP Biote Corp. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Biote Corp. stock. As of the latest transaction made, Marshall Wace, LLP holds 10,900 shares of BTMD stock, worth $83,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,900Holding current value
$83,385% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BTMD
# of Institutions
56Shares Held
12.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$28.8 Million10.43% of portfolio
-
Bandera Partners LLC New York, NY2.01MShares$15.3 Million4.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$10.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY973KShares$7.44 Million0.0% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL838KShares$6.41 Million3.21% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $57.9M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...